Sequential Conditioning in Haploidentical Transplantation for Hematopoietic Stem Cells in Patients With Relapsed or Refractory Lymphoid Hematological Disorders

Inclusion Criteria: * Patients with an indication of allo-HSC for a lymphoid hematological malignancy like Hodgkin's lymphoma, non hodgkin's lymphoma b cell (mantle follicular, diffuse large cells, marginal zone,MALT) or T (peripheral T whithout specificity, anaplasic, angio-immunoblastic, natural killer cells, gamma / delta T cells, Sezary's syndrome, primitive cutaneous T), prolymphocytic leukemia, chronic lymphocytic leukemia, waldenström's disease and for which a therapeutic strategie combining a sequential chemotherapy followed by the reduced-intensity conditioning(SET RIC + PDLI) is decided * Patients at least in partial response (standard criteria) after a rescue treatment the day of evaluation at 1 month before the conditioning * Advanced age ≥ 18 to \<60 years * Cardiac ejection fraction of the left ventricle ≥ 45% * Lung function - free diffusion capacity for carbon monoxide ≥ 50% of predicted value * Creatinine clearance ≥ 50 ml / min depending on the CKD-EPI formula * Availability of an HLA haploidentical donor in the family * Collection of non-opposition Exclusion Criteria: * Invasion of uncontrolled CNS * Availability of an HLA identical family donor who agreed to donate hematopoietic stem cells OR non-related donor HLA-compatible 10/10 on HLA-A alleles, B, C, and DRB1 DQB1 available and ready to give in 4 weeks to make a decision allograft * Presence in the patient HLA-specific antibodies directed against an antigen HLA haploidentical donor family * Karnofsky score \<70% * Patient HIV positive * Hepatitis B or C or chronic active * Uncontrolled infection at the time of start packing * Contraindication to the use of treatments provided by the protocol * Previous history of allo-HSC * No beneficiary of a social security scheme. * life expentancy estimated less than 1 month by investigator